Clinical Trials Browser

Phase 3 × INDUSTRY × Adrenal Cortex Hormones × Clear all

NCT06925737 2026-03-13

MK-2400-001

Phase 3 Recruiting

Prostatic Neoplasms

NCT02046603 2018-12-07

ACT-MOVE

Phase 3 Completed

162 enrolled 30 charts

Arthritis, Rheumatoid

NCT00661102 2016-11-02

A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).

Phase 3 Completed

Breast Neoplasms